Back To Index  <<  Back To Terminology

final Value Set eHDSIRareDisease 2022‑06‑23 15:36:00

Id 1.3.6.1.4.1.12559.11.10.1.3.1.42.63 Effective Date 2022‑06‑23 15:36:00
Status final Final Version Label 202206
Name eHDSIRareDisease Display Name eHDSIRareDisease
Description The Value Set is used to describe the problems and medication reasons.
Usage: 3
Id Name Type
Template
1.3.6.1.4.1.12559.11.10.1.3.1.3.41 eHDSI Medication Reason Observation DYNAMIC
1.3.6.1.4.1.12559.11.10.1.3.1.3.41 eHDSI Medication Reason Observation DYNAMIC
1.3.6.1.4.1.12559.11.10.1.3.1.3.7 eHDSI Problem DYNAMIC
Source Code System
1.3.6.1.4.1.12559.11.10.1.3.1.44.5 - ORPHAnet - FHIR: urn:oid:1.3.6.1.4.1.12559.11.10.1.3.1.44.5
Level/ Type Code Display Name Code System
0‑L
5
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
ORPHAnet
0‑L
6
3-methylcrotonyl-CoA carboxylase deficiency
ORPHAnet
0‑L
7
3C syndrome
ORPHAnet
0‑L
8
47,XYY syndrome
ORPHAnet
0‑L
9
Tetrasomy X
ORPHAnet
0‑L
10
48,XXYY syndrome
ORPHAnet
0‑L
11
Pentasomy X
ORPHAnet
0‑L
13
6-pyruvoyl-tetrahydropterin synthase deficiency
ORPHAnet
0‑L
14
Abetalipoproteinemia
ORPHAnet
0‑L
15
Achondroplasia
ORPHAnet
0‑L
16
Blue cone monochromatism
ORPHAnet
0‑L
17
Fatal infantile lactic acidosis with methylmalonic aciduria
ORPHAnet
0‑L
18
Distal renal tubular acidosis
ORPHAnet
0‑L
20
3-hydroxy-3-methylglutaric aciduria
ORPHAnet
0‑L
22
Succinic semialdehyde dehydrogenase deficiency
ORPHAnet
0‑L
23
Argininosuccinic aciduria
ORPHAnet
0‑L
24
Fumaric aciduria
ORPHAnet
0‑L
25
Glutaryl-CoA dehydrogenase deficiency
ORPHAnet
0‑L
26
Methylmalonic acidemia with homocystinuria
ORPHAnet
0‑L
27
Vitamin B12-unresponsive methylmalonic acidemia
ORPHAnet
0‑L
28
Vitamin B12-responsive methylmalonic acidemia
ORPHAnet
0‑L
29
Mevalonic aciduria
ORPHAnet
0‑L
30
Hereditary orotic aciduria
ORPHAnet
0‑L
31
Oxoglutaric aciduria
ORPHAnet
0‑L
32
Glutathione synthetase deficiency
ORPHAnet
0‑L
33
Isovaleric acidemia
ORPHAnet
0‑L
35
Propionic acidemia
ORPHAnet
0‑L
36
Acrocallosal syndrome
ORPHAnet
0‑L
37
Acrodermatitis enteropathica
ORPHAnet
0‑L
38
Acrokeratoelastoidosis of Costa
ORPHAnet
0‑L
39
Acromelanosis
ORPHAnet
0‑L
40
Acromesomelic dysplasia, Maroteaux type
ORPHAnet
0‑L
41
Dyschromatosis symmetrica hereditaria
ORPHAnet
0‑L
42
Medium chain acyl-CoA dehydrogenase deficiency
ORPHAnet
0‑L
43
X-linked adrenoleukodystrophy
ORPHAnet
0‑L
44
Neonatal adrenoleukodystrophy
ORPHAnet
0‑L
45
Adenosine monophosphate deaminase deficiency
ORPHAnet
0‑L
46
Adenylosuccinate lyase deficiency
ORPHAnet
0‑L
47
X-linked agammaglobulinemia
ORPHAnet
0‑L
48
Congenital bilateral absence of vas deferens
ORPHAnet
0‑L
49
Penile agenesis
ORPHAnet
0‑L
50
Aicardi syndrome
ORPHAnet
0‑L
51
Aicardi-Goutières syndrome
ORPHAnet
0‑L
52
Alagille syndrome
ORPHAnet
0‑L
53
Albers-Schönberg osteopetrosis
ORPHAnet
0‑L
54
X-linked recessive ocular albinism
ORPHAnet
0‑L
56
Alkaptonuria
ORPHAnet
0‑L
57
Glycogen storage disease due to aldolase A deficiency
ORPHAnet
0‑L
58
Alexander disease
ORPHAnet
0‑L
59
Allan-Herndon-Dudley syndrome
ORPHAnet
0‑L
60
Alpha-1-antitrypsin deficiency
ORPHAnet
0‑L
61
Alpha-mannosidosis
ORPHAnet
0‑L
62
Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3
ORPHAnet
0‑L
63
Alport syndrome
ORPHAnet
0‑L
64
Alström syndrome
ORPHAnet
0‑L
65
Leber congenital amaurosis
ORPHAnet
0‑L
67
Amoebiasis due to Entamoeba histolytica
ORPHAnet
0‑L
68
Amoebiasis due to free-living amoebae
ORPHAnet
0‑L
70
Proximal spinal muscular atrophy
ORPHAnet
0‑L
71
Chylomicron retention disease
ORPHAnet
0‑L
72
Angelman syndrome
ORPHAnet
0‑L
73
Gorham-Stout disease
ORPHAnet
0‑L
74
Angiostrongyliasis
ORPHAnet
0‑L
76
Strongyloidiasis
ORPHAnet
0‑L
78
Ankylostomiasis
ORPHAnet
0‑L
79
Congenital alpha2-antiplasmin deficiency
ORPHAnet
0‑L
80
Antiphospholipid syndrome
ORPHAnet
0‑L
81
Antisynthetase syndrome
ORPHAnet
0‑L
82
Hereditary thrombophilia due to congenital antithrombin deficiency
ORPHAnet
0‑L
83
Antley-Bixler syndrome
ORPHAnet
0‑L
84
Fanconi anemia
ORPHAnet
0‑L
86
Familial abdominal aortic aneurysm
ORPHAnet
0‑L
87
Apert syndrome
ORPHAnet
0‑L
88
Idiopathic aplastic anemia
ORPHAnet
0‑L
90
Argininemia
ORPHAnet
0‑L
91
Aromatase deficiency
ORPHAnet
0‑L
93
Aspartylglucosaminuria
ORPHAnet
0‑L
95
Friedreich ataxia
ORPHAnet
0‑L
96
Ataxia with vitamin E deficiency
ORPHAnet
0‑L
97
Familial paroxysmal ataxia
ORPHAnet
0‑L
98
Autosomal recessive spastic ataxia of Charlevoix-Saguenay
ORPHAnet
0‑L
100
Ataxia-telangiectasia
ORPHAnet
0‑L
101
Dentatorubral pallidoluysian atrophy
ORPHAnet
0‑L
102
Multiple system atrophy
ORPHAnet
0‑L
104
Leber hereditary optic neuropathy
ORPHAnet
0‑L
105
Atresia of urethra
ORPHAnet
0‑L
107
BOR syndrome
ORPHAnet
0‑L
108
Babesiosis
ORPHAnet
0‑L
109
Bannayan-Riley-Ruvalcaba syndrome
ORPHAnet
0‑L
110
Bardet-Biedl syndrome
ORPHAnet
0‑L
111
Barth syndrome
ORPHAnet
0‑L
112
Bartter syndrome
ORPHAnet
0‑L
113
Bazex-Dupré-Christol syndrome
ORPHAnet
0‑L
114
Auriculoosteodysplasia
ORPHAnet
0‑L
115
Congenital contractural arachnodactyly
ORPHAnet
0‑L
116
Beckwith-Wiedemann syndrome
ORPHAnet
0‑L
117
Behçet disease
ORPHAnet
0‑L
118
Beta-mannosidosis
ORPHAnet
0‑L
119
Beta-sarcoglycan-related limb-girdle muscular dystrophy R4
ORPHAnet
0‑L
122
Birt-Hogg-Dubé syndrome
ORPHAnet
0‑L
123
Björnstad syndrome
ORPHAnet
0‑L
124
Blackfan-Diamond anemia
ORPHAnet
0‑L
125
Bloom syndrome
ORPHAnet
0‑L
126
Blepharophimosis-ptosis-epicanthus inversus syndrome
ORPHAnet
0‑L
127
Borjeson-Forssman-Lehmann syndrome
ORPHAnet
0‑L
128
Diphyllobothriasis
ORPHAnet
0‑L
129
Pseudopelade of Brocq
ORPHAnet
0‑L
130
Brugada syndrome
ORPHAnet
0‑L
131
Budd-Chiari syndrome
ORPHAnet
0‑L
132
Butyrylcholinesterase deficiency
ORPHAnet
0‑L
133
Chronic beryllium disease
ORPHAnet
0‑L
134
Beta-ketothiolase deficiency
ORPHAnet
0‑L
135
CACH syndrome
ORPHAnet
0‑L
136
Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy
ORPHAnet
0‑L
138
CHARGE syndrome
ORPHAnet
0‑L
139
CHILD syndrome
ORPHAnet
0‑L
140
Campomelic dysplasia
ORPHAnet
0‑L
141
Canavan disease
ORPHAnet
0‑L
142
Anaplastic thyroid carcinoma
ORPHAnet
0‑L
143
Parathyroid carcinoma
ORPHAnet
0‑L
144
Lynch syndrome
ORPHAnet
0‑L
145
Hereditary breast and ovarian cancer syndrome
ORPHAnet
0‑L
146
Differentiated thyroid carcinoma
ORPHAnet
0‑L
147
Carbamoyl-phosphate synthetase 1 deficiency
ORPHAnet
0‑L
150
Nasopharyngeal carcinoma
ORPHAnet
0‑L
154
Familial isolated dilated cardiomyopathy
ORPHAnet
0‑L
156
Carnitine palmitoyl transferase 1A deficiency
ORPHAnet
0‑L
157
Carnitine palmitoyltransferase II deficiency
ORPHAnet
0‑L
158
Systemic primary carnitine deficiency
ORPHAnet
0‑L
159
Carnitine-acylcarnitine translocase deficiency
ORPHAnet
0‑L
160
Castleman disease
ORPHAnet
0‑L
162
Cataract-glaucoma syndrome
ORPHAnet
0‑L
163
Hereditary hyperferritinemia-cataract syndrome
ORPHAnet
0‑L
167
Chédiak-Higashi syndrome
ORPHAnet
0‑L
168
Loose anagen syndrome
ORPHAnet
0‑L
169
Ringed hair disease
ORPHAnet
0‑L
170
Woolly hair
ORPHAnet
0‑L
171
Primary sclerosing cholangitis
ORPHAnet
0‑L
172
Progressive familial intrahepatic cholestasis
ORPHAnet
0‑L
173
Cholera
ORPHAnet
0‑L
174
Metaphyseal chondrodysplasia, Schmid type
ORPHAnet
0‑L
175
Cartilage-hair hypoplasia
ORPHAnet
0‑L
177
Rhizomelic chondrodysplasia punctata
ORPHAnet
0‑L
178
Chordoma
ORPHAnet
0‑L
179
Birdshot chorioretinopathy
ORPHAnet
0‑L
180
Choroideremia
ORPHAnet
0‑L
181
X-linked hypohidrotic ectodermal dysplasia
ORPHAnet
0‑L
182
Chromomycosis
ORPHAnet
0‑L
183
Eosinophilic granulomatosis with polyangiitis
ORPHAnet
0‑L
184
Cherubism
ORPHAnet
0‑L
185
Scimitar syndrome
ORPHAnet
0‑L
186
Primary biliary cholangitis
ORPHAnet
0‑L
188
Systemic capillary leak syndrome
ORPHAnet
0‑L
189
Hidrotic ectodermal dysplasia
ORPHAnet
0‑L
190
Coats disease
ORPHAnet
0‑L
191
Cockayne syndrome
ORPHAnet
0‑L
192
Coffin-Lowry syndrome
ORPHAnet
0‑L
193
Cohen syndrome
ORPHAnet
0‑L
195
Cat-eye syndrome
ORPHAnet
0‑L
198
Occipital horn syndrome
ORPHAnet
0‑L
199
Cornelia de Lange syndrome
ORPHAnet
0‑L
200
Isolated corpus callosum agenesis
ORPHAnet
0‑L
201
Cowden syndrome
ORPHAnet
0‑L
202
Crandall syndrome
ORPHAnet
0‑L
204
Sporadic Creutzfeldt-Jakob disease
ORPHAnet
0‑L
205
Crigler-Najjar syndrome
ORPHAnet
0‑L
207
Crouzon syndrome
ORPHAnet
0‑L
210
Cyclosporosis
ORPHAnet
0‑L
211
Familial cylindromatosis
ORPHAnet
0‑L
212
Cystathioninuria
ORPHAnet
0‑L
213
Cystinosis
ORPHAnet
0‑L
214
Cystinuria
ORPHAnet
0‑L
215
Congenital stationary night blindness
ORPHAnet
0‑L
217
Isolated Dandy-Walker malformation
ORPHAnet
0‑L
218
Darier disease
ORPHAnet
0‑L
219
Delta-sarcoglycan-related limb-girdle muscular dystrophy R6
ORPHAnet
0‑L
220
Denys-Drash syndrome
ORPHAnet
0‑L
221
Dermatomyositis
ORPHAnet
0‑L
222
Erosive pustular dermatosis of the scalp
ORPHAnet
0‑L
223
Nephrogenic diabetes insipidus
ORPHAnet
0‑L
225
Maternally-inherited diabetes and deafness
ORPHAnet
0‑L
226
Dihydropteridine reductase deficiency
ORPHAnet
0‑L
227
Diphallia
ORPHAnet
0‑L
229
Familial aortic dissection
ORPHAnet
0‑L
230
Dopamine beta-hydroxylase deficiency
ORPHAnet
0‑L
231
Dracunculiasis
ORPHAnet
0‑L
232
Sickle cell anemia
ORPHAnet
0‑L
233
Duane retraction syndrome
ORPHAnet
0‑L
234
Dubin-Johnson syndrome
ORPHAnet
0‑L
235
Dubowitz syndrome
ORPHAnet
0‑L
236
Trisomy 9p
ORPHAnet
0‑L
237
Duplication of urethra
ORPHAnet
0‑L
238
Digestive duplication
ORPHAnet
0‑L
239
Dyggve-Melchior-Clausen disease
ORPHAnet
0‑L
240
Léri-Weill dyschondrosteosis
ORPHAnet
0‑L
241
Dyschromatosis universalis hereditaria
ORPHAnet
0‑L
242
46,XY complete gonadal dysgenesis
ORPHAnet
0‑L
243
46,XX gonadal dysgenesis
ORPHAnet
0‑L
244
Primary ciliary dyskinesia
ORPHAnet
0‑L
245
Nager syndrome
ORPHAnet
0‑L
246
Postaxial acrofacial dysostosis
ORPHAnet
0‑L
248
Autosomal recessive hypohidrotic ectodermal dysplasia
ORPHAnet
0‑L
249
Fibrous dysplasia of bone
ORPHAnet
0‑L
256
Early-onset generalized limb-onset dystonia
ORPHAnet
0‑L
257
Epidermolysis bullosa simplex with muscular dystrophy
ORPHAnet
0‑L
258
Laminin subunit alpha 2-related congenital muscular dystrophy
ORPHAnet
0‑L
261
Emery-Dreifuss muscular dystrophy
ORPHAnet
0‑L
266
Autosomal dominant limb-girdle muscular dystrophy type 1A
ORPHAnet
0‑L
267
Calpain-3-related limb-girdle muscular dystrophy R1
ORPHAnet
0‑L
268
Dysferlin-related limb-girdle muscular dystrophy R2
ORPHAnet
0‑L
269
Facioscapulohumeral dystrophy
ORPHAnet
0‑L
270
Oculopharyngeal muscular dystrophy
ORPHAnet
0‑L
272
Congenital muscular dystrophy, Fukuyama type
ORPHAnet
0‑L
273
Steinert myotonic dystrophy
ORPHAnet
0‑L
274
Bernard-Soulier syndrome
ORPHAnet
0‑L
275
Severe combined immunodeficiency due to DCLRE1C deficiency
ORPHAnet
0‑L
276
T-B+ severe combined immunodeficiency due to gamma chain deficiency
ORPHAnet
0‑L
277
Severe combined immunodeficiency due to adenosine deaminase deficiency
ORPHAnet
0‑L
280
Wolf-Hirschhorn syndrome
ORPHAnet
0‑L
281
Monosomy 5p
ORPHAnet
0‑L
283
Demodicidosis
ORPHAnet
0‑L
284
Alveolar echinococcosis
ORPHAnet
0‑L
285
Hypermobile Ehlers-Danlos syndrome
ORPHAnet
0‑L
286
Vascular Ehlers-Danlos syndrome
ORPHAnet
0‑L
287
Classical Ehlers-Danlos syndrome
ORPHAnet
0‑L
288
Hereditary elliptocytosis
ORPHAnet
0‑L
289
Ellis Van Creveld syndrome
ORPHAnet
0‑L
290
Congenital rubella syndrome
ORPHAnet
0‑L
291
Congenital varicella syndrome
ORPHAnet
0‑L
292
Congenital enterovirus infection
ORPHAnet
0‑L
293
Congenital herpes simplex virus infection
ORPHAnet
0‑L
294
Fetal cytomegalovirus syndrome
ORPHAnet
0‑L
295
Fetal parvovirus syndrome
ORPHAnet
0‑L
296
Ollier disease
ORPHAnet
0‑L
297
Tick-borne encephalitis
ORPHAnet
0‑L
298
Mitochondrial neurogastrointestinal encephalomyopathy
ORPHAnet
0‑L
300
Bifunctional enzyme deficiency
ORPHAnet
0‑L
302
Epidermodysplasia verruciformis
ORPHAnet
0‑L
306
Benign familial infantile epilepsy
ORPHAnet
0‑L
307
Juvenile myoclonic epilepsy
ORPHAnet
0‑L
308
Progressive myoclonic epilepsy type 1
ORPHAnet
0‑L
312
Autosomal dominant epidermolytic ichthyosis
ORPHAnet
0‑L
313
Lamellar ichthyosis
ORPHAnet
0‑L
314
Erythroderma desquamativum
ORPHAnet
0‑L
315
Erythrokeratoderma ''en cocardes''
ORPHAnet
0‑L
316
Progressive symmetric erythrokeratodermia
ORPHAnet
0‑L
317
Erythrokeratodermia variabilis
ORPHAnet
0‑L
318
Acute erythroid leukemia
ORPHAnet
0‑L
319
Skeletal Ewing sarcoma
ORPHAnet
0‑L
320
Apparent mineralocorticoid excess
ORPHAnet
0‑L
321
Multiple osteochondromas
ORPHAnet
0‑L
322
Exstrophy-epispadias complex
ORPHAnet
0‑L
324
Fabry disease
ORPHAnet
0‑L
325
Congenital factor II deficiency
ORPHAnet
0‑L
326
Congenital factor V deficiency
ORPHAnet
0‑L
327
Congenital factor VII deficiency
ORPHAnet
0‑L
328
Congenital factor X deficiency
ORPHAnet
0‑L
329
Congenital factor XI deficiency
ORPHAnet
0‑L
330
Congenital factor XII deficiency
ORPHAnet
0‑L
331
Congenital factor XIII deficiency
ORPHAnet
0‑L
332
Congenital intrinsic factor deficiency
ORPHAnet
0‑L
333
Farber disease
ORPHAnet
0‑L
334
Familial atrial fibrillation
ORPHAnet
0‑L
335
Congenital fibrinogen deficiency
ORPHAnet
0‑L
337
Fibrodysplasia ossificans progressiva
ORPHAnet
0‑L
340
Hemorrhagic fever-renal syndrome
ORPHAnet
0‑L
342
Familial Mediterranean fever
ORPHAnet
0‑L
343
Hyperimmunoglobulinemia D with periodic fever
ORPHAnet
0‑L
345
Dissecting cellulitis of the scalp
ORPHAnet
0‑L
346
Quinquaud folliculitis decalvans
ORPHAnet
0‑L
347
Frasier syndrome
ORPHAnet
0‑L
348
Fructose-1,6-bisphosphatase deficiency
ORPHAnet
0‑L
349
Fucosidosis
ORPHAnet
0‑L
351
Galactosialidosis
ORPHAnet
0‑L
353
Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5
ORPHAnet
0‑L
354
GM1 gangliosidosis
ORPHAnet
0‑L
355
Gaucher disease
ORPHAnet
0‑L
356
Gerstmann-Straussler-Scheinker syndrome
ORPHAnet
0‑L
358
Gitelman syndrome
ORPHAnet
0‑L
360
Glioblastoma
ORPHAnet
0‑L
361
Familial glucocorticoid deficiency
ORPHAnet
0‑L
364
Glycogen storage disease due to glucose-6-phosphatase deficiency
ORPHAnet
0‑L
365
Glycogen storage disease due to acid maltase deficiency
ORPHAnet
0‑L
366
Glycogen storage disease due to glycogen debranching enzyme deficiency
ORPHAnet
0‑L
367
Glycogen storage disease due to glycogen branching enzyme deficiency
ORPHAnet
0‑L
368
Glycogen storage disease due to muscle glycogen phosphorylase deficiency
ORPHAnet
0‑L
369
Glycogen storage disease due to liver glycogen phosphorylase deficiency
ORPHAnet
0‑L
371
Glycogen storage disease due to muscle phosphofructokinase deficiency
ORPHAnet
0‑L
373
Simpson-Golabi-Behmel syndrome
ORPHAnet
0‑L
375
Anti-glomerular basement membrane disease
ORPHAnet
0‑L
376
Gordon syndrome
ORPHAnet
0‑L
377
Gorlin syndrome
ORPHAnet
0‑L
379
Chronic granulomatous disease
ORPHAnet
0‑L
380
Greig cephalopolysyndactyly syndrome
ORPHAnet
0‑L
381
Griscelli syndrome
ORPHAnet
0‑L
382
Guanidinoacetate methyltransferase deficiency
ORPHAnet
0‑L
384
Huriez syndrome
ORPHAnet
0‑L
386
Hepatic cystic hamartoma
ORPHAnet
0‑L
388
Hirschsprung disease
ORPHAnet
0‑L
389
Langerhans cell histiocytosis
ORPHAnet
0‑L
390
Histoplasmosis
ORPHAnet
0‑L
391
Classic Hodgkin lymphoma
ORPHAnet
0‑L
392
Holt-Oram syndrome
ORPHAnet
0‑L
393
46,XX testicular disorder of sex development
ORPHAnet
0‑L
394
Classic homocystinuria
ORPHAnet
0‑L
395
Homocystinuria due to methylene tetrahydrofolate reductase deficiency
ORPHAnet
0‑L
396
Chronic hiccup
ORPHAnet
0‑L
397
Giant cell arteritis
ORPHAnet
0‑L
399
Huntington disease
ORPHAnet
0‑L
400
Cystic echinococcosis
ORPHAnet
0‑L
401
Hymenolepiasis
ORPHAnet
0‑L
403
Familial hyperaldosteronism type I
ORPHAnet
0‑L
404
Familial hyperaldosteronism type II
ORPHAnet
0‑L
405
Familial hypocalciuric hypercalcemia
ORPHAnet
0‑L
407
Glycine encephalopathy
ORPHAnet
0‑L
408
Isolated glycerol kinase deficiency
ORPHAnet
0‑L
409
Hyperkeratosis lenticularis perstans
ORPHAnet
0‑L
412
Dysbetalipoproteinemia
ORPHAnet
0‑L
414
Gyrate atrophy of choroid and retina
ORPHAnet
0‑L
415
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
ORPHAnet
0‑L
416
Primary hyperoxaluria
ORPHAnet
0‑L
417
Neonatal severe primary hyperparathyroidism
ORPHAnet
0‑L
419
Hyperprolinemia type 1
ORPHAnet
0‑L
422
Idiopathic/heritable pulmonary arterial hypertension
ORPHAnet
0‑L
423
Malignant hyperthermia of anesthesia
ORPHAnet
0‑L
424
Familial hyperthyroidism due to mutations in TSH receptor
ORPHAnet
0‑L
425
Apolipoprotein A-I deficiency
ORPHAnet
0‑L
427
Familial hypoaldosteronism
ORPHAnet
0‑L
428
Autosomal dominant hypocalcemia
ORPHAnet
0‑L
429
Hypochondroplasia
ORPHAnet
0‑L
432
Normosmic congenital hypogonadotropic hypogonadism
ORPHAnet
0‑L
436
Hypophosphatasia
ORPHAnet
0‑L
439
Isolated right ventricular hypoplasia
ORPHAnet
0‑L
441
Pure autonomic failure
ORPHAnet
0‑L
444
Marie Unna hereditary hypotrichosis
ORPHAnet
0‑L
446
Neonatal hemochromatosis
ORPHAnet
0‑L
447
Paroxysmal nocturnal hemoglobinuria
ORPHAnet
0‑L
449
Hepatoblastoma
ORPHAnet
0‑L
452
X-linked lissencephaly with abnormal genitalia
ORPHAnet
0‑L
454
Acquired ichthyosis
ORPHAnet
0‑L
455
Superficial epidermolytic ichthyosis
ORPHAnet
0‑L
457
Harlequin ichthyosis
ORPHAnet
0‑L
461
Recessive X-linked ichthyosis
ORPHAnet
0‑L
464
Incontinentia pigmenti
ORPHAnet
0‑L
465
Congenital plasminogen activator inhibitor type 1 deficiency
ORPHAnet
0‑L
466
Fatal familial insomnia
ORPHAnet
0‑L
469
Hereditary fructose intolerance
ORPHAnet
0‑L
470
Lysinuric protein intolerance
ORPHAnet
0‑L
472
Isosporiasis
ORPHAnet
0‑L
474
Jeune syndrome
ORPHAnet
0‑L
475
Joubert syndrome
ORPHAnet
0‑L
477
KID syndrome
ORPHAnet
0‑L
478
Kallmann syndrome
ORPHAnet
0‑L
480
Kearns-Sayre syndrome
ORPHAnet
0‑L
481
Kennedy disease
ORPHAnet
0‑L
482
Kimura disease
ORPHAnet
0‑L
483
Congenital high-molecular-weight kininogen deficiency
ORPHAnet
0‑L
485
Kniest dysplasia
ORPHAnet
0‑L
486
Autosomal dominant severe congenital neutropenia
ORPHAnet
0‑L
487
Krabbe disease
ORPHAnet
0‑L
488
Urachal cyst
ORPHAnet
0‑L
490
Omphalomesenteric cyst
ORPHAnet
0‑L
492
Proliferating trichilemmal cyst
ORPHAnet
0‑L
493
Familial keratoacanthoma
ORPHAnet
0‑L
494
Keratoderma hereditarium mutilans
ORPHAnet
0‑L
495
Transgrediens et progrediens palmoplantar keratoderma
ORPHAnet
0‑L
499
Kerion celsi
ORPHAnet
0‑L
500
Noonan syndrome with multiple lentigines
ORPHAnet
0‑L
501
Lafora disease
ORPHAnet
0‑L
502
Trichorhinophalangeal syndrome type 2
ORPHAnet
0‑L
503
Larsen syndrome
ORPHAnet
0‑L
504
Creeping myiasis
ORPHAnet
0‑L
505
Graham Little-Piccardi-Lassueur syndrome
ORPHAnet
0‑L
507
Leishmaniasis
ORPHAnet
0‑L
508
Leprechaunism
ORPHAnet
0‑L
509
Leptospirosis
ORPHAnet
0‑L
510
Lesch-Nyhan syndrome
ORPHAnet
0‑L
511
Maple syrup urine disease
ORPHAnet
0‑L
512
Metachromatic leukodystrophy
ORPHAnet
0‑L
514
Acute monoblastic/monocytic leukemia
ORPHAnet
0‑L
517
Acute myelomonocytic leukemia
ORPHAnet
0‑L
518
Acute megakaryoblastic leukemia
ORPHAnet
0‑L
520
Acute promyelocytic leukemia
ORPHAnet
0‑L
521
Chronic myeloid leukemia
ORPHAnet
0‑L
523
Hereditary leiomyomatosis and renal cell cancer
ORPHAnet
0‑L
524
Li-Fraumeni syndrome
ORPHAnet
0‑L
525
Lichen planopilaris
ORPHAnet
0‑L
526
Liddle syndrome
ORPHAnet
0‑L
528
Congenital generalized lipodystrophy
ORPHAnet
0‑L
529
Roch-Leri mesosomatous lipomatosis
ORPHAnet
0‑L
530
Lipoid proteinosis
ORPHAnet
0‑L
531
Miller-Dieker syndrome
ORPHAnet
0‑L
533
Listeriosis
ORPHAnet
0‑L
534
Oculocerebrorenal syndrome of Lowe
ORPHAnet
0‑L
536
Systemic lupus erythematosus
ORPHAnet
0‑L
537
Toxic epidermal necrolysis
ORPHAnet
0‑L
538
Lymphangioleiomyomatosis
ORPHAnet
0‑L
540
Familial hemophagocytic lymphohistiocytosis
ORPHAnet
0‑L
543
Burkitt lymphoma
ORPHAnet
0‑L
545
Follicular lymphoma
ORPHAnet
0‑L
548
Leprosy
ORPHAnet
0‑L
549
Legionnaires disease
ORPHAnet
0‑L
550
MELAS
ORPHAnet
0‑L
551
MERRF
ORPHAnet
0‑L
552
MODY
ORPHAnet
0‑L
556
Malakoplakia
ORPHAnet
0‑L
558
Marfan syndrome
ORPHAnet
0‑L
559
Marinesco-Sjögren syndrome
ORPHAnet
0‑L
560
Marshall syndrome
ORPHAnet
0‑L
561
Marshall-Smith syndrome
ORPHAnet
0‑L
562
McCune-Albright syndrome
ORPHAnet
0‑L
563
Peripartum cardiomyopathy
ORPHAnet
0‑L
564
Meckel syndrome
ORPHAnet
0‑L
565
Menkes disease
ORPHAnet
0‑L
566
Congenital microcoria
ORPHAnet
0‑L
567
22q11.2 deletion syndrome
ORPHAnet
0‑L
568
Microphthalmia, Lenz type
ORPHAnet
0‑L
569
Familial or sporadic hemiplegic migraine
ORPHAnet
0‑L
570
Moebius syndrome
ORPHAnet
0‑L
572
Immunodeficiency by defective expression of MHC class II
ORPHAnet
0‑L
573
Monilethrix
ORPHAnet
0‑L
574
Monosomy 21
ORPHAnet
0‑L
575
Muckle-Wells syndrome
ORPHAnet
0‑L
576
Mucolipidosis type II
ORPHAnet
0‑L
577
Mucolipidosis type III
ORPHAnet
0‑L
578
Mucolipidosis type IV
ORPHAnet
0‑L
579
Mucopolysaccharidosis type 1
ORPHAnet
0‑L
580
Mucopolysaccharidosis type 2
ORPHAnet
0‑L
581
Mucopolysaccharidosis type 3
ORPHAnet
0‑L
582
Mucopolysaccharidosis type 4
ORPHAnet
0‑L
583
Mucopolysaccharidosis type 6
ORPHAnet
0‑L
584
Mucopolysaccharidosis type 7
ORPHAnet
0‑L
585
Multiple sulfatase deficiency
ORPHAnet
0‑L
586
Cystic fibrosis
ORPHAnet
0‑L
587
Muir-Torre syndrome
ORPHAnet
0‑L
588
Muscle-eye-brain disease
ORPHAnet
0‑L
589
Myasthenia gravis
ORPHAnet
0‑L
590
Congenital myasthenic syndrome
ORPHAnet
0‑L
591
Furuncular myiasis
ORPHAnet
0‑L
592
Macrophagic myofasciitis
ORPHAnet
0‑L
596
X-linked centronuclear myopathy
ORPHAnet
0‑L
597
Central core disease
ORPHAnet
0‑L
598
Multiminicore myopathy
ORPHAnet
0‑L
600
Vocal cord and pharyngeal distal myopathy
ORPHAnet
0‑L
602
GNE myopathy
ORPHAnet
0‑L
603
Distal myopathy, Welander type
ORPHAnet
0‑L
606
Proximal myotonic myopathy
ORPHAnet
0‑L
609
Tibial muscular dystrophy
ORPHAnet
0‑L
610
Bethlem myopathy
ORPHAnet
0‑L
611
Inclusion body myositis
ORPHAnet
0‑L
614
Thomsen and Becker disease
ORPHAnet
0‑L
615
Familial atrial myxoma
ORPHAnet
0‑L
616
Medulloblastoma
ORPHAnet
0‑L
617
Congenital primary megaureter
ORPHAnet
0‑L
618
Familial melanoma
ORPHAnet
0‑L
621
Hereditary methemoglobinemia
ORPHAnet
0‑L
622
Homocystinuria without methylmalonic aciduria
ORPHAnet
0‑L
624
Familial multiple nevi flammei
ORPHAnet
0‑L
626
Large congenital melanocytic nevus
ORPHAnet
0‑L
627
Nance-Horan syndrome
ORPHAnet
0‑L
628
Diastrophic dysplasia
ORPHAnet
0‑L
629
Short stature due to growth hormone qualitative anomaly
ORPHAnet
0‑L
631
Non-acquired isolated growth hormone deficiency
ORPHAnet
0‑L
632
Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia
ORPHAnet
0‑L
633
Laron syndrome
ORPHAnet
0‑L
634
Netherton syndrome
ORPHAnet
0‑L
635
Neuroblastoma
ORPHAnet
0‑L
636
Neurofibromatosis type 1
ORPHAnet
0‑L
637
Neurofibromatosis type 2
ORPHAnet
0‑L
638
Neurofibromatosis-Noonan syndrome
ORPHAnet
0‑L
639
Polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG
ORPHAnet
0‑L
640
Hereditary neuropathy with liability to pressure palsies
ORPHAnet
0‑L
641
Multifocal motor neuropathy
ORPHAnet
0‑L
642
Hereditary sensory and autonomic neuropathy type 4
ORPHAnet
0‑L
643
Giant axonal neuropathy
ORPHAnet
0‑L
644
NARP syndrome
ORPHAnet
0‑L
646
Niemann-Pick disease type C
ORPHAnet
0‑L
647
Nijmegen breakage syndrome
ORPHAnet
0‑L
648
Noonan syndrome
ORPHAnet
0‑L
649
Norrie disease
ORPHAnet
0‑L
650
LCAT deficiency
ORPHAnet
0‑L
652
Multiple endocrine neoplasia type 1
ORPHAnet
0‑L
653
Multiple endocrine neoplasia type 2
ORPHAnet
0‑L
654
Nephroblastoma
ORPHAnet
0‑L
655
Nephronophthisis
ORPHAnet
0‑L
656
Genetic steroid-resistant nephrotic syndrome
ORPHAnet
0‑L
659
Mutilating palmoplantar keratoderma with periorificial keratotic plaques
ORPHAnet
0‑L
660
Omphalocele
ORPHAnet
0‑L
661
Congenital central hypoventilation syndrome
ORPHAnet
0‑L
662
Yellow nail syndrome
ORPHAnet
0‑L
663
Mitochondrial DNA-related progressive external ophthalmoplegia
ORPHAnet
0‑L
664
Ornithine transcarbamylase deficiency
ORPHAnet
0‑L
666
Osteogenesis imperfecta
ORPHAnet
0‑L
667
Autosomal recessive malignant osteopetrosis
ORPHAnet
0‑L
668
Osteosarcoma
ORPHAnet
0‑L
672
Pallister-Hall syndrome
ORPHAnet
0‑L
673
Malaria
ORPHAnet
0‑L
674
Accessory pancreas
ORPHAnet
0‑L
675
Annular pancreas
ORPHAnet
This value set has 7226 codes in it. In order to keep the publication size manageable, only a selection (500 codes) of the whole set of codes is shown.

Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.
download XML JSON CSV SQL SVS